Chi B. Vu
Impact in
- Physiology top 2%
- Adenosine and Purinergic Signaling
- Geriatrics and Gerontology top 2%
- Sirtuins and Resveratrol in Medicine
Papers in
-
- Synthesis and Biological Evaluation 5
- Asymmetric Synthesis and Catalysis 4
- Chemical synthesis and alkaloids 3
-
- Chemical Synthesis and Analysis 7
- Protein Kinase Regulation and GTPase Signaling 4
- Peroxisome Proliferator-Activated Receptors 3
- Co-authors
- Harry H. Wasserman (8 shared papers)Russell C. Petter (6 shared papers)G. Kumaravel (5 shared papers)Thomas M. Engber (5 shared papers)Xiaowei Jin (5 shared papers)Michael R. Jirousek (6 shared papers)Jill C. Milne (5 shared papers)Bo Peng (4 shared papers)
- Journals
- Journal of Medicinal Chemistry (10 papers)Bioorganic & Medicinal Chemistry Letters (9 papers)Tetrahedron Letters (6 papers)Arteriosclerosis Thrombosis and Vascular Biology (1 paper)Tetrahedron (1 paper)
- Partner nations
- United StatesNetherlandsSwitzerland
In The Last Decade
Chi B. Vu
35 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 100
- Physiology 180
- Geriatrics and Gerontology 106
- Organic Chemistry 540
- Pharmacology 87
- Molecular Biology 368
Countries citing papers authored by Chi B. Vu
This map shows the geographic impact of Chi B. Vu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chi B. Vu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chi B. Vu more than expected).
Fields of papers citing papers by Chi B. Vu
This network shows the impact of papers produced by Chi B. Vu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chi B. Vu. The network helps show where Chi B. Vu may publish in the future.
Co-authors
The 25 scholars most cited alongside Chi B. Vu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1997 | 131 | |
| 2 | 2009 | 106 | |
| 3 | 2008 | 82 | |
| 4 | 1999 | 80 | |
| 5 | 2004 | 70 | |
| 6 | 2004 | 60 | |
| 7 | 2004 | 56 | |
| 8 | 2001 | 47 | |
| 9 | 2004 | 41 | |
| 10 | 1999 | 35 | |
| 11 | 2004 | 33 | |
| 12 | 2016 | 32 | |
| 13 | 2000 | 30 | |
| 14 | 1990 | 30 | |
| 15 | 2009 | 25 | |
| 16 | 2016 | 23 | |
| 17 | 1992 | 20 | |
| 18 | 1990 | 20 | |
| 19 | 1994 | 19 | |
| 20 | 2017 | 18 |
About Chi B. Vu
Chi B. Vu is a scholar working on Organic Chemistry, Molecular Biology, Physiology, Surgery and Oncology, having authored 36 papers that have together received 1.1k indexed citations. Recurring topics across this work include Adenosine and Purinergic Signaling (7 papers), Chemical Synthesis and Analysis (7 papers), Synthesis and Biological Evaluation (5 papers), Protein Kinase Regulation and GTPase Signaling (4 papers), Asymmetric Synthesis and Catalysis (4 papers), Peroxisome Proliferator-Activated Receptors (3 papers), Synthesis and Biological Activity (3 papers) and Chemical synthesis and alkaloids (3 papers). The work is most often cited by research in Physiology (180 citations), Geriatrics and Gerontology (106 citations), Organic Chemistry (540 citations), Pharmacology (87 citations) and Molecular Biology (368 citations). Chi B. Vu has collaborated with scholars based in United States, Netherlands and Switzerland. Frequent co-authors include Harry H. Wasserman, Russell C. Petter, G. Kumaravel, Thomas M. Engber, Xiaowei Jin, Michael R. Jirousek, Jill C. Milne, Bo Peng, David P. Carney and Robert B. Perni. Their work appears in journals such as Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters, Tetrahedron Letters, Arteriosclerosis Thrombosis and Vascular Biology and Tetrahedron.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.